APO Research
Talk to an analyst

APO RESEARCH · REPORT

Procalcitonin

Procalcitonin (PCT), CAS 56645-65-9, is a 116 amino acid residue protein with a molecular weight of approximately 13kDa. Procalcitonin is a peptide hormone mainly produced by the C cells of the thyroid and certain endocrine cells of the lung. Under normal expression conditions, procalcitonin is immediately cleaved into three specific fragments, an N terminal residue, calcitonin and katacalcin. It can be expressed in E. coli

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Procalcitonin (PCT), CAS 56645-65-9, is a 116 amino acid residue protein with a molecular weight of approximately 13kDa. Procalcitonin is a peptide hormone mainly produced by the C cells of the thyroid and certain endocrine cells of the lung. Under normal expression conditions, procalcitonin is immediately cleaved into three specific fragments, an N terminal residue, calcitonin and katacalcin. It can be expressed in E. coli

Selected research

Industry Growth & Trends

Global Procalcitonin Industry Growth and Trends Forecast to 2032

8 January 2026115 pages

Choose your research edition.

Industry ResearchProcalcitonin Industry Research Report 2026132 pages · $2,950 USDIndustry Growth & TrendsGlobal Procalcitonin Industry Growth and Trends Forecast to 2032115 pages · $3,450 USDMarket StructureGlobal Procalcitonin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Procalcitonin Market Outlook and Growth Opportunities 2026206 pages · $4,250 USDMarket Analysis & ForecastGlobal Procalcitonin Market Analysis and Forecast 2026-2032205 pages · $4,950 USD

Market perspective

Procalcitonin (PCT), CAS 56645-65-9, is a 116 amino acid residue protein with a molecular weight of approximately 13kDa. Procalcitonin is a peptide hormone mainly produced by the C cells of the thyroid and certain endocrine cells of the lung. Under normal expression conditions, procalcitonin is immediately cleaved into three specific fragments, an N terminal residue, calcitonin and katacalcin. It can be expressed in E. coli

Global Procalcitonin (CAS 56645-65-9) key players include Thermo Fisher, bioMerieux, BBI Solutions, Roche Diagnostics, HyTest, etc. Global top five manufacturers hold a share about 35%. Asia Pacific and Europe is the largest market, both with a share about 30%, followed by North America, with a share about 25 percent. In terms of product, Procalcitonin Antigen is the largest segment, with a share about 80%. And in terms of application, the largest application is Medical Industry, followed by Scientific Research, and Veterinarian.

Report Scope

Read the full market overview

This report provides a structured, data-driven view of the global Procalcitonin market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Procalcitonin market size, estimates, and forecasts are presented in terms of sales volume (mg) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Procalcitonin market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Procalcitonin.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Procalcitonin market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Procalcitonin Market by Company

Thermo Fisher

Roche Diagnostics

bioMerieux

HyTest

BBI Solutions

ProSpec

Wondfo

Ningbo Medicalsystem Biotechnology

Wuhan Easy Diagnosis Biomedicine

Snibe

Vazyme Biotech

Getein Biotech

Hotgen Biotech

Lumigenex

Nanjing Norman Biological Technology

Kitgen

Beijing KeyGen

Beijing Apis

Procalcitonin Segment by Type

Procalcitonin Antigen

Procalcitonin Antibody

Procalcitonin Segment by Application

Medical Industry

Scientific Research

Veterinarian

Procalcitonin Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Procalcitonin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Procalcitonin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Procalcitonin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Procalcitonin manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Procalcitonin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Procalcitonin Antigen Table 2. Major Company of Procalcitonin Antibody Table 3. Global Procalcitonin Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Procalcitonin Sales by Type (2021-2026) & (mg) Table 5. Global Procalcitonin Sales Market Share in Volume by Type (2021-2026) Table 6. Global Procalcitonin Sales by Type (2021-2026) & (US$ Million) Table 7. Global Procalcitonin Sales Market Share in Value by Type (2021-2026) Table 8. Global Procalcitonin Price by Type (2021-2026) & (USD/mg) Table 9. Global Procalcitonin Sales by Type (2027-2032) & (mg) Table 10. Global Procalcitonin Sales Market Share in Volume by Type (2027-2032) Table 11. Global Procalcitonin Sales by Type (2027-2032) & (US$ Million) Table 12. Global Procalcitonin Sales Market Share in Value by Type (2027-2032) Table 13. Global Procalcitonin Price by Type (2027-2032) & (USD/mg) Table 14. North America Procalcitonin Sales by Type (2021-2026) & (mg) Table 15. North America Procalcitonin Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Procalcitonin Sales by Type (2021-2026) & (mg) Table 17. Europe Procalcitonin Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Procalcitonin Sales by Type (2021-2026) & (mg) Table 19. Asia-Pacific Procalcitonin Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Procalcitonin Sales by Type (2021-2026) & (mg) Table 21. Latin America Procalcitonin Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Procalcitonin Sales by Type (2021-2026) & (mg) Table 23. Middle East and Africa Procalcitonin Sales by Type (2021-2026) & (US$ Million) Table 24. Procalcitonin Industry Trends Table 25. Procalcitonin Industry Drivers Table 26. Procalcitonin Industry Opportunities and Challenges Table 27. Procalcitonin Industry Restraints Table 28. Global Procalcitonin Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Procalcitonin Revenue Market Share by Company (2021-2026) Table 30. Global Procalcitonin Sales by Company (2021-2026) & (mg) Table 31. Global Procalcitonin Sales Share by Company (2021-2026) Table 32. Global Procalcitonin Market Price by Company (2021-2026) & (USD/mg) Table 33. Global Procalcitonin Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Procalcitonin Major Company Production Sites and Headquarters Table 35. Global Procalcitonin Company, Product Type & Application Table 36. Global Procalcitonin Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Procalcitonin by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Procalcitonin Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Procalcitonin Sales by Region (2021-2026) & (mg) Table 41. Global Procalcitonin Sales Market Share in Volume by Region (2021-2026) Table 42. Global Procalcitonin Sales by Region (2021-2026) & (US$ Million) Table 43. Global Procalcitonin Sales Market Share in Value by Region (2021-2026) Table 44. Global Procalcitonin Sales (mg), Value (US$ Million), Price (USD/mg) and Gross Margin (2021-2026) Table 45. Global Procalcitonin Sales by Region (2027-2032) & (mg) Table 46. Global Procalcitonin Sales Market Share in Volume by Region (2027-2032) Table 47. Global Procalcitonin Sales by Region (2027-2032) & (US$ Million) Table 48. Global Procalcitonin Sales Market Share in Value by Region (2027-2032) Table 49. Global Procalcitonin Sales (mg), Value (US$ Million), Price (USD/mg) and Gross Margin (2027-2032) Table 50. Global Procalcitonin Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Procalcitonin Sales by Application (2021-2026) & (mg) Table 52. Global Procalcitonin Sales Market Share in Volume by Application (2021-2026) Table 53. Global Procalcitonin Sales by Application (2021-2026) & (US$ Million) Table 54. Global Procalcitonin Sales Market Share in Value by Application (2021-2026) Table 55. Global Procalcitonin Price by Application (2021-2026) & (USD/mg) Table 56. Global Procalcitonin Sales by Application (2027-2032) & (mg) Table 57. Global Procalcitonin Sales Market Share in Volume by Application (2027-2032) Table 58. Global Procalcitonin Sales by Application (2027-2032) & (US$ Million) Table 59. Global Procalcitonin Sales Market Share in Value by Application (2027-2032) Table 60. Global Procalcitonin Price by Application (2027-2032) & (USD/mg) Table 61. North America Procalcitonin Sales by Application (2021-2026) & (mg) Table 62. North America Procalcitonin Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Procalcitonin Sales by Application (2021-2026) & (mg) Table 64. Europe Procalcitonin Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Procalcitonin Sales by Application (2021-2026) & (mg) Table 66. Asia-Pacific Procalcitonin Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Procalcitonin Sales by Application (2021-2026) & (mg) Table 68. Latin America Procalcitonin Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Procalcitonin Sales by Application (2021-2026) & (mg) Table 70. Middle East and Africa Procalcitonin Sales by Application (2021-2026) & (US$ Million) Table 71. Thermo Fisher Company Information Table 72. Thermo Fisher Business Overview Table 73. Thermo Fisher Procalcitonin Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2021-2026) Table 74. Thermo Fisher Procalcitonin Product Portfolio Table 75. Thermo Fisher Recent Development Table 76. Roche Diagnostics Company Information Table 77. Roche Diagnostics Business Overview Table 78. Roche Diagnostics Procalcitonin Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2021-2026) Table 79. Roche Diagnostics Procalcitonin Product Portfolio Table 80. Roche Diagnostics Recent Development Table 81. bioMerieux Company Information Table 82. bioMerieux Business Overview Table 83. bioMerieux Procalcitonin Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2021-2026) Table 84. bioMerieux Procalcitonin Product Portfolio Table 85. bioMerieux Recent Development Table 86. HyTest Company Information Table 87. HyTest Business Overview Table 88. HyTest Procalcitonin Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2021-2026) Table 89. HyTest Procalcitonin Product Portfolio Table 90. HyTest Recent Development Table 91. BBI Solutions Company Information Table 92. BBI Solutions Business Overview Table 93. BBI Solutions Procalcitonin Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2021-2026) Table 94. BBI Solutions Procalcitonin Product Portfolio Table 95. BBI Solutions Recent Development Table 96. ProSpec Company Information Table 97. ProSpec Business Overview Table 98. ProSpec Procalcitonin Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2021-2026) Table 99. ProSpec Procalcitonin Product Portfolio Table 100. ProSpec Recent Development Table 101. Wondfo Company Information Table 102. Wondfo Business Overview Table 103. Wondfo Procalcitonin Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2021-2026) Table 104. Wondfo Procalcitonin Product Portfolio Table 105. Wondfo Recent Development Table 106. Ningbo Medicalsystem Biotechnology Company Information Table 107. Ningbo Medicalsystem Biotechnology Business Overview Table 108. Ningbo Medicalsystem Biotechnology Procalcitonin Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2021-2026) Table 109. Ningbo Medicalsystem Biotechnology Procalcitonin Product Portfolio Table 110. Ningbo Medicalsystem Biotechnology Recent Development Table 111. Wuhan Easy Diagnosis Biomedicine Company Information Table 112. Wuhan Easy Diagnosis Biomedicine Business Overview Table 113. Wuhan Easy Diagnosis Biomedicine Procalcitonin Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2021-2026) Table 114. Wuhan Easy Diagnosis Biomedicine Procalcitonin Product Portfolio Table 115. Wuhan Easy Diagnosis Biomedicine Recent Development Table 116. Snibe Company Information Table 117. Snibe Business Overview Table 118. Snibe Procalcitonin Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2021-2026) Table 119. Snibe Procalcitonin Product Portfolio Table 120. Snibe Recent Development Table 121. Vazyme Biotech Company Information Table 122. Vazyme Biotech Business Overview Table 123. Vazyme Biotech Procalcitonin Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2021-2026) Table 124. Vazyme Biotech Procalcitonin Product Portfolio Table 125. Vazyme Biotech Recent Development Table 126. Getein Biotech Company Information Table 127. Getein Biotech Business Overview Table 128. Getein Biotech Procalcitonin Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2021-2026) Table 129. Getein Biotech Procalcitonin Product Portfolio Table 130. Getein Biotech Recent Development Table 131. Hotgen Biotech Company Information Table 132. Hotgen Biotech Business Overview Table 133. Hotgen Biotech Procalcitonin Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2021-2026) Table 134. Hotgen Biotech Procalcitonin Product Portfolio Table 135. Hotgen Biotech Recent Development Table 136. Lumigenex Company Information Table 137. Lumigenex Business Overview Table 138. Lumigenex Procalcitonin Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2021-2026) Table 139. Lumigenex Procalcitonin Product Portfolio Table 140. Lumigenex Recent Development Table 141. Nanjing Norman Biological Technology Company Information Table 142. Nanjing Norman Biological Technology Business Overview Table 143. Nanjing Norman Biological Technology Procalcitonin Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2021-2026) Table 144. Nanjing Norman Biological Technology Procalcitonin Product Portfolio Table 145. Nanjing Norman Biological Technology Recent Development Table 146. Kitgen Company Information Table 147. Kitgen Business Overview Table 148. Kitgen Procalcitonin Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2021-2026) Table 149. Kitgen Procalcitonin Product Portfolio Table 150. Kitgen Recent Development Table 151. Beijing KeyGen Company Information Table 152. Beijing KeyGen Business Overview Table 153. Beijing KeyGen Procalcitonin Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2021-2026) Table 154. Beijing KeyGen Procalcitonin Product Portfolio Table 155. Beijing KeyGen Recent Development Table 156. Beijing Apis Company Information Table 157. Beijing Apis Business Overview Table 158. Beijing Apis Procalcitonin Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2021-2026) Table 159. Beijing Apis Procalcitonin Product Portfolio Table 160. Beijing Apis Recent Development Table 161. North America Procalcitonin Market Size Growth Rate (CAGR) by Country (mg): 2021 VS 2025 VS 2032 Table 162. North America Procalcitonin Sales by Country (2021-2026) & (mg) Table 163. North America Procalcitonin Sales Market Share by Country (2021-2026) Table 164. North America Procalcitonin Sales Forecast by Country (2027-2032) & (mg) Table 165. North America Procalcitonin Sales Market Share Forecast by Country (2027-2032) Table 166. North America Procalcitonin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 167. North America Procalcitonin Market Size by Country (2021-2026) & (US$ Million) Table 168. North America Procalcitonin Market Share by Country (2021-2026) Table 169. North America Procalcitonin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 170. North America Procalcitonin Market Share Forecast by Country (2027-2032) Table 171. Europe Procalcitonin Market Size Growth Rate (CAGR) by Country (mg): 2021 VS 2025 VS 2032 Table 172. Europe Procalcitonin Sales by Country (2021-2026) & (mg) Table 173. Europe Procalcitonin Sales Market Share by Country (2021-2026) Table 174. Europe Procalcitonin Sales Forecast by Country (2027-2032) & (mg) Table 175. Europe Procalcitonin Sales Market Share Forecast by Country (2027-2032) Table 176. Europe Procalcitonin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 177. Europe Procalcitonin Market Size by Country (2021-2026) & (US$ Million) Table 178. Europe Procalcitonin Market Share by Country (2021-2026) Table 179. Europe Procalcitonin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 180. Europe Procalcitonin Market Share Forecast by Country (2027-2032) Table 181. Asia-Pacific Procalcitonin Market Size Growth Rate (CAGR) by Country (mg): 2021 VS 2025 VS 2032 Table 182. Asia-Pacific Procalcitonin Sales by Country (2021-2026) & (mg) Table 183. Asia-Pacific Procalcitonin Sales Market Share by Country (2021-2026) Table 184. Asia-Pacific Procalcitonin Sales Forecast by Country (2027-2032) & (mg) Table 185. Asia-Pacific Procalcitonin Sales Market Share Forecast by Country (2027-2032) Table 186. Asia-Pacific Procalcitonin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 187. Asia-Pacific Procalcitonin Market Size by Country (2021-2026) & (US$ Million) Table 188. Asia-Pacific Procalcitonin Market Share by Country (2021-2026) Table 189. Asia-Pacific Procalcitonin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 190. Asia-Pacific Procalcitonin Market Share Forecast by Country (2027-2032) Table 191. Latin America Procalcitonin Market Size Growth Rate (CAGR) by Country (mg): 2021 VS 2025 VS 2032 Table 192. Latin America Procalcitonin Sales by Country (2021-2026) & (mg) Table 193. Latin America Procalcitonin Sales Market Share by Country (2021-2026) Table 194. Latin America Procalcitonin Sales Forecast by Country (2027-2032) & (mg) Table 195. Latin America Procalcitonin Sales Market Share Forecast by Country (2027-2032) Table 196. Latin America Procalcitonin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 197. Latin America Procalcitonin Market Size by Country (2021-2026) & (US$ Million) Table 198. Latin America Procalcitonin Market Share by Country (2021-2026) Table 199. Latin America Procalcitonin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 200. Latin America Procalcitonin Market Share Forecast by Country (2027-2032) Table 201. Middle East and Africa Procalcitonin Market Size Growth Rate (CAGR) by Country (mg): 2021 VS 2025 VS 2032 Table 202. Middle East and Africa Procalcitonin Sales by Country (2021-2026) & (mg) Table 203. Middle East and Africa Procalcitonin Sales Market Share by Country (2021-2026) Table 204. Middle East and Africa Procalcitonin Sales Forecast by Country (2027-2032) & (mg) Table 205. Middle East and Africa Procalcitonin Sales Market Share Forecast by Country (2027-2032) Table 206. Middle East and Africa Procalcitonin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 207. Middle East and Africa Procalcitonin Market Size by Country (2021-2026) & (US$ Million) Table 208. Middle East and Africa Procalcitonin Market Share by Country (2021-2026) Table 209. Middle East and Africa Procalcitonin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 210. Middle East and Africa Procalcitonin Market Share Forecast by Country (2027-2032) Table 211. Key Raw Materials Table 212. Raw Materials Key Suppliers Table 213. Procalcitonin Distributors List Table 214. Procalcitonin Customers List Table 215. Research Programs/Design for This Report Table 216. Authors List of This Report Table 217. Secondary Sources Table 218. Primary Sources List of Figures Figure 1. Procalcitonin Image Figure 2. Global Procalcitonin Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Procalcitonin Market Size (2021-2032) & (US$ Million) Figure 4. Global Procalcitonin Sales (2021-2032) & (mg) Figure 5. Procalcitonin Antigen Image Figure 6. Global Procalcitonin Antigen Sales YoY Growth (2021-2032) & (mg) Figure 7. Procalcitonin Antibody Image Figure 8. Global Procalcitonin Antibody Sales YoY Growth (2021-2032) & (mg) Figure 9. Global Procalcitonin Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Procalcitonin Market Share by Type 2025 VS 2032 Figure 11. North America Procalcitonin Sales Market Share in Volume by Type in 2025 Figure 12. North America Procalcitonin Sales Market Share in Value by Type in 2025 Figure 13. Europe Procalcitonin Sales Market Share in Volume by Type in 2025 Figure 14. Europe Procalcitonin Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Procalcitonin Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Procalcitonin Sales Market Share in Value by Type in 2025 Figure 17. Latin America Procalcitonin Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Procalcitonin Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Procalcitonin Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Procalcitonin Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Procalcitonin Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Medical Industry Image Figure 24. Global Medical Industry Sales YoY Growth (2021-2032) & (mg) Figure 25. Scientific Research Image Figure 26. Global Scientific Research Sales YoY Growth (2021-2032) & (mg) Figure 27. Veterinarian Image Figure 28. Global Veterinarian Sales YoY Growth (2021-2032) & (mg) Figure 29. Global Procalcitonin Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Procalcitonin Market Share by Application 2025 VS 2032 Figure 31. North America Procalcitonin Sales Market Share in Volume by Application in 2025 Figure 32. North America Procalcitonin Sales Market Share in Value by Application in 2025 Figure 33. Europe Procalcitonin Sales Market Share in Volume by Application in 2025 Figure 34. Europe Procalcitonin Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Procalcitonin Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Procalcitonin Sales Market Share in Value by Application in 2025 Figure 37. Latin America Procalcitonin Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Procalcitonin Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Procalcitonin Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Procalcitonin Sales Market Share in Value by Application in 2025 Figure 41. North America Procalcitonin Sales by Country: 2021 VS 2025 VS 2032 (mg) Figure 42. North America Procalcitonin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Procalcitonin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Procalcitonin Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Procalcitonin Sales by Country: 2021 VS 2025 VS 2032 (mg) Figure 46. Europe Procalcitonin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Procalcitonin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Procalcitonin Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Procalcitonin Sales by Country: 2021 VS 2025 VS 2032 (mg) Figure 50. Asia-Pacific Procalcitonin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Procalcitonin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Procalcitonin Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Procalcitonin Sales by Country: 2021 VS 2025 VS 2032 (mg) Figure 54. Latin America Procalcitonin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Procalcitonin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Procalcitonin Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Procalcitonin Sales by Country: 2021 VS 2025 VS 2032 (mg) Figure 58. Middle East and Africa Procalcitonin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Procalcitonin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Procalcitonin Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Procalcitonin Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Procalcitonin Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Procalcitonin Antigen
  • Procalcitonin Antibody
Applications
  • Medical Industry
  • Scientific Research
  • Veterinarian
Companies covered
  • Thermo Fisher
  • Roche Diagnostics
  • bioMerieux
  • HyTest
  • BBI Solutions
  • ProSpec
  • Wondfo
  • Ningbo Medicalsystem Biotechnology
  • Wuhan Easy Diagnosis Biomedicine
  • Snibe
  • Vazyme Biotech
  • Getein Biotech
  • Hotgen Biotech
  • Lumigenex
  • Nanjing Norman Biological Technology
  • Kitgen
  • Beijing KeyGen
  • Beijing Apis

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Procalcitonin Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Procalcitonin Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Procalcitonin Market by Type
  6. 1.3.1 Procalcitonin Antigen
  7. 1.3.2 Procalcitonin Antibody
  8. 1.4 Global Procalcitonin Market Size by Type
  9. 1.4.1 Global Procalcitonin Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Procalcitonin Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Procalcitonin Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Procalcitonin Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Procalcitonin Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Procalcitonin Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Procalcitonin Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Procalcitonin Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Procalcitonin Industry Trends
  2. 2.2 Procalcitonin Industry Drivers
  3. 2.3 Procalcitonin Industry Opportunities and Challenges
  4. 2.4 Procalcitonin Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Procalcitonin Revenue (2021-2026)
  2. 3.2 Global Top Players by Procalcitonin Sales (2021-2026)
  3. 3.3 Global Top Players by Procalcitonin Price (2021-2026)
  4. 3.4 Global Procalcitonin Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Procalcitonin Major Company Production Sites & Headquarters
  6. 3.6 Global Procalcitonin Company, Product Type & Application
  7. 3.7 Global Procalcitonin Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Procalcitonin Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Procalcitonin Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Procalcitonin Tier 1, Tier 2, and Tier 3
4 Procalcitonin Regional Status and Outlook
  1. 4.1 Global Procalcitonin Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Procalcitonin Historic Market Size by Region
  3. 4.2.1 Global Procalcitonin Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Procalcitonin Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Procalcitonin Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Procalcitonin Forecasted Market Size by Region
  7. 4.3.1 Global Procalcitonin Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Procalcitonin Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Procalcitonin Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Procalcitonin by Application
  1. 5.1 Procalcitonin Market by Application
  2. 5.1.1 Medical Industry
  3. 5.1.2 Scientific Research
  4. 5.1.3 Veterinarian
  5. 5.2 Global Procalcitonin Market Size by Application
  6. 5.2.1 Global Procalcitonin Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Procalcitonin Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Procalcitonin Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Procalcitonin Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Procalcitonin Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Procalcitonin Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Procalcitonin Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Procalcitonin Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Thermo Fisher
  2. 6.1.1 Thermo Fisher Company Information
  3. 6.1.2 Thermo Fisher Business Overview
  4. 6.1.3 Thermo Fisher Procalcitonin Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Thermo Fisher Procalcitonin Product Portfolio
  6. 6.1.5 Thermo Fisher Recent Developments
  7. 6.2 Roche Diagnostics
  8. 6.2.1 Roche Diagnostics Company Information
  9. 6.2.2 Roche Diagnostics Business Overview
  10. 6.2.3 Roche Diagnostics Procalcitonin Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Roche Diagnostics Procalcitonin Product Portfolio
  12. 6.2.5 Roche Diagnostics Recent Developments
  13. 6.3 bioMerieux
  14. 6.3.1 bioMerieux Company Information
  15. 6.3.2 bioMerieux Business Overview
  16. 6.3.3 bioMerieux Procalcitonin Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 bioMerieux Procalcitonin Product Portfolio
  18. 6.3.5 bioMerieux Recent Developments
  19. 6.4 HyTest
  20. 6.4.1 HyTest Company Information
  21. 6.4.2 HyTest Business Overview
  22. 6.4.3 HyTest Procalcitonin Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 HyTest Procalcitonin Product Portfolio
  24. 6.4.5 HyTest Recent Developments
  25. 6.5 BBI Solutions
  26. 6.5.1 BBI Solutions Company Information
  27. 6.5.2 BBI Solutions Business Overview
  28. 6.5.3 BBI Solutions Procalcitonin Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 BBI Solutions Procalcitonin Product Portfolio
  30. 6.5.5 BBI Solutions Recent Developments
  31. 6.6 ProSpec
  32. 6.6.1 ProSpec Company Information
  33. 6.6.2 ProSpec Business Overview
  34. 6.6.3 ProSpec Procalcitonin Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 ProSpec Procalcitonin Product Portfolio
  36. 6.6.5 ProSpec Recent Developments
  37. 6.7 Wondfo
  38. 6.7.1 Wondfo Company Information
  39. 6.7.2 Wondfo Business Overview
  40. 6.7.3 Wondfo Procalcitonin Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Wondfo Procalcitonin Product Portfolio
  42. 6.7.5 Wondfo Recent Developments
  43. 6.8 Ningbo Medicalsystem Biotechnology
  44. 6.8.1 Ningbo Medicalsystem Biotechnology Company Information
  45. 6.8.2 Ningbo Medicalsystem Biotechnology Business Overview
  46. 6.8.3 Ningbo Medicalsystem Biotechnology Procalcitonin Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Ningbo Medicalsystem Biotechnology Procalcitonin Product Portfolio
  48. 6.8.5 Ningbo Medicalsystem Biotechnology Recent Developments
  49. 6.9 Wuhan Easy Diagnosis Biomedicine
  50. 6.9.1 Wuhan Easy Diagnosis Biomedicine Company Information
  51. 6.9.2 Wuhan Easy Diagnosis Biomedicine Business Overview
  52. 6.9.3 Wuhan Easy Diagnosis Biomedicine Procalcitonin Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Wuhan Easy Diagnosis Biomedicine Procalcitonin Product Portfolio
  54. 6.9.5 Wuhan Easy Diagnosis Biomedicine Recent Developments
  55. 6.10 Snibe
  56. 6.10.1 Snibe Company Information
  57. 6.10.2 Snibe Business Overview
  58. 6.10.3 Snibe Procalcitonin Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Snibe Procalcitonin Product Portfolio
  60. 6.10.5 Snibe Recent Developments
  61. 6.11 Vazyme Biotech
  62. 6.11.1 Vazyme Biotech Company Information
  63. 6.11.2 Vazyme Biotech Business Overview
  64. 6.11.3 Vazyme Biotech Procalcitonin Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Vazyme Biotech Procalcitonin Product Portfolio
  66. 6.11.5 Vazyme Biotech Recent Developments
  67. 6.12 Getein Biotech
  68. 6.12.1 Getein Biotech Company Information
  69. 6.12.2 Getein Biotech Business Overview
  70. 6.12.3 Getein Biotech Procalcitonin Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Getein Biotech Procalcitonin Product Portfolio
  72. 6.12.5 Getein Biotech Recent Developments
  73. 6.13 Hotgen Biotech
  74. 6.13.1 Hotgen Biotech Company Information
  75. 6.13.2 Hotgen Biotech Business Overview
  76. 6.13.3 Hotgen Biotech Procalcitonin Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Hotgen Biotech Procalcitonin Product Portfolio
  78. 6.13.5 Hotgen Biotech Recent Developments
  79. 6.14 Lumigenex
  80. 6.14.1 Lumigenex Company Information
  81. 6.14.2 Lumigenex Business Overview
  82. 6.14.3 Lumigenex Procalcitonin Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Lumigenex Procalcitonin Product Portfolio
  84. 6.14.5 Lumigenex Recent Developments
  85. 6.15 Nanjing Norman Biological Technology
  86. 6.15.1 Nanjing Norman Biological Technology Company Information
  87. 6.15.2 Nanjing Norman Biological Technology Business Overview
  88. 6.15.3 Nanjing Norman Biological Technology Procalcitonin Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Nanjing Norman Biological Technology Procalcitonin Product Portfolio
  90. 6.15.5 Nanjing Norman Biological Technology Recent Developments
  91. 6.16 Kitgen
  92. 6.16.1 Kitgen Company Information
  93. 6.16.2 Kitgen Business Overview
  94. 6.16.3 Kitgen Procalcitonin Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Kitgen Procalcitonin Product Portfolio
  96. 6.16.5 Kitgen Recent Developments
  97. 6.17 Beijing KeyGen
  98. 6.17.1 Beijing KeyGen Company Information
  99. 6.17.2 Beijing KeyGen Business Overview
  100. 6.17.3 Beijing KeyGen Procalcitonin Sales, Revenue and Gross Margin (2021-2026)
  101. 6.17.4 Beijing KeyGen Procalcitonin Product Portfolio
  102. 6.17.5 Beijing KeyGen Recent Developments
  103. 6.18 Beijing Apis
  104. 6.18.1 Beijing Apis Company Information
  105. 6.18.2 Beijing Apis Business Overview
  106. 6.18.3 Beijing Apis Procalcitonin Sales, Revenue and Gross Margin (2021-2026)
  107. 6.18.4 Beijing Apis Procalcitonin Product Portfolio
  108. 6.18.5 Beijing Apis Recent Developments
7 North America by Country
  1. 7.1 North America Procalcitonin Sales by Country
  2. 7.1.1 North America Procalcitonin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Procalcitonin Sales by Country (2021-2026)
  4. 7.1.3 North America Procalcitonin Sales Forecast by Country (2027-2032)
  5. 7.2 North America Procalcitonin Market Size by Country
  6. 7.2.1 North America Procalcitonin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Procalcitonin Market Size by Country (2021-2026)
  8. 7.2.3 North America Procalcitonin Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Procalcitonin Sales by Country
  2. 8.1.1 Europe Procalcitonin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Procalcitonin Sales by Country (2021-2026)
  4. 8.1.3 Europe Procalcitonin Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Procalcitonin Market Size by Country
  6. 8.2.1 Europe Procalcitonin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Procalcitonin Market Size by Country (2021-2026)
  8. 8.2.3 Europe Procalcitonin Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Procalcitonin Sales by Country
  2. 9.1.1 Asia-Pacific Procalcitonin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Procalcitonin Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Procalcitonin Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Procalcitonin Market Size by Country
  6. 9.2.1 Asia-Pacific Procalcitonin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Procalcitonin Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Procalcitonin Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Procalcitonin Sales by Country
  2. 10.1.1 South America Procalcitonin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Procalcitonin Sales by Country (2021-2026)
  4. 10.1.3 South America Procalcitonin Sales Forecast by Country (2027-2032)
  5. 10.2 South America Procalcitonin Market Size by Country
  6. 10.2.1 South America Procalcitonin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Procalcitonin Market Size by Country (2021-2026)
  8. 10.2.3 South America Procalcitonin Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Procalcitonin Sales by Country
  2. 11.1.1 Middle East and Africa Procalcitonin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Procalcitonin Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Procalcitonin Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Procalcitonin Market Size by Country
  6. 11.2.1 Middle East and Africa Procalcitonin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Procalcitonin Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Procalcitonin Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Procalcitonin Value Chain Analysis
  2. 12.1.1 Procalcitonin Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Procalcitonin Production Mode & Process
  7. 12.2 Procalcitonin Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Procalcitonin Distributors
  10. 12.2.3 Procalcitonin Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst